Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Outbrain Inc	852	21. nov 2024	4.68	-1.27
Outfront Media Inc	76C	21. nov 2024	17.80	0.00
Outlook Therapeutics	41O	21. nov 2024	4.94	+1.23
Outokumpu	OUTA	21. nov 2024	3.17	-0.66
OUTSURANCE GROUP LTD.	RMQ0	21. nov 2024	3.28	+1.86
Ovation Science Inc Common Shares (Canada)	0VH	21. nov 2024	0.01	0.00
Ovb Holding	O4B	21. nov 2024	19.50	0.00
Oversea-chinese Banking Corp	OCBB	21. nov 2024	23.00	0.00
Oversea-Chinese Banking Corporation Limited	OCBA	21. nov 2024	11.52	-0.13
Overstock.com, Inc.	OVER	21. nov 2024	5.29	-1.71
OVH Groupe	7U7	21. nov 2024	8.25	-0.54
OVH GROUPE UNSP.ADR/1/2	7U70	21. nov 2024	3.54	-1.12
Ovid Therapeutics Inc.	1OT	21. nov 2024	0.94	+0.53
Ovintiv Inc. (DE)	47Q	21. nov 2024	43.06	+2.89
Ovs SPA	0OV1	21. nov 2024	2.87	+1.05
Ovzon	OVZ	21. nov 2024	1.26	+9.77
Owens & Minor, Inc.	6OM	21. nov 2024	11.20	-1.75
Owens Corning Inc	O5Q	21. nov 2024	182.45	+1.79
Owl Rock Capital Corporation	1D6	21. nov 2024	14.20	-0.01
OXE Marine	5LK	21. nov 2024	0.00	-88.89
Oxford BioDynamics plc	LMQ	21. nov 2024	0.00	0.00
Oxford Biomedica	OXOA	21. nov 2024	4.82	0.00
Oxford Industries, Inc.	OXD	21. nov 2024	70.50	+1.44
Oxford Instruments PLC	OX3	21. nov 2024	23.20	-2.52
Oxford Lane Capital Corp.	4RQ	21. nov 2024	5.03	0.00
Oxford Lane Capital Corp. - 6.25% Series 2027 Term Preferred	4RQ0	21. nov 2024	22.60	+0.89
Oxford Metrics plc	RNI	21. nov 2024	0.72	-2.03
Oxford Square Capital Corp. - Closed End Fund	22T	21. nov 2024	2.50	-1.38
Oxley Holdings Limited	8OX1	21. nov 2024	0.04	-1.12
Oxurion NV	TG40	21. nov 2024	0.27	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.